Professionals and Partners
Go to Professionals and Partners

Professionals and Partners

Our core expertise is the development and manufacturing of high-quality generic and in-licensed medicines with a proven cost-effectiveness ratio.

Individuals and Families
Go to Individuals and Families

Individuals and Families

We believe in improving the life of individuals and families by using the best current research. We use our resources to drive future scientific and manufacturing development for the constant betterment of therapies.

Home

Tchaikapharma High Quality Medicines Inc. is devoted to providing individuals and families with a wide range of affordable contemporary high-quality pharmaceuticals fighting socially significant diseases.

  • October 21, 2022

    The newest medicinal product to receive Marketing Authorization from the Medicines Executive Agency is: Semefro 50 mg/850 mg film-coated tablets Semefro 50 mg/1000 mg film-coated tablets   Active ingredients: sitagliptin/metformin hydrochloride   Semefro contains two different medicines called sitagliptin and metformin. – Sitagliptin belongs to a class of medicines called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) […]

  • October 19, 2022

    The turnover from transactions with Bulgarian shares reached just under BGN 6 million, and two-thirds of it (just over BGN 4 million) was formed by transactions with shares of Tchaikapharma High Quality Medicines. Another 4 companies formed another quarter of the turnover, SOFIX recorded a minimal decrease.   Read the full article here in Bulgarian.

  • October 5, 2022

    Tchaikapharma has launched two new medicinal products on the market, which are already commercially available: Methylprednisolone-Chaikapharma (methylprednisolone) 40 mg powder and solvent for for injection solution TromBai (cilostazol) 100 mg tablets   The distributor of the medicinal products is Commercial League – Global Pharmа Center.

  • July 8, 2022

    On July 7, 2022, the Bulgarian Credit Rating Agency (BCRA) has awarded the company with the highest market capitalization on the Bulgarian Stock Exchange Tchaikapharma a long-term credit rating of “BBB-” and a short-term “A” on a national scale. With this, BCRA expresses its opinion that the company maintains a very good financial position with […]

  • July 4, 2022

    “Politicians in power have one main task – to create a competitive investment and business environment and deal with the growth of the national economy. The self-esteem of any nation is a product of GDP per capita. Politicians should focus on this issue.” This is what Tihomir Kamenov, a specialist in public and private law, […]